Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Progression‐free survival · people with chronic lymphocytic leukaemia

Anti‐CD20 mAb maintenance therapy probably leads to lower progression‐free survival compared with observation (moderate certainty).

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
HR 0.61 [0.5, 0.73]
5 studies · 1255 participants
Moderate